KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioNTech SE (BNTX) Other Accumulated Expenses (2019 - 2024)

Historic Other Accumulated Expenses for BioNTech SE (BNTX) over the last 8 years, with Q2 2025 value amounting to -$8.3 million.

  • BioNTech SE's Other Accumulated Expenses fell 369.35% to -$8.3 million in Q2 2025 from the same period last year, while for Jun 2025 it was -$8.3 million, marking a year-over-year decrease of 369.35%. This contributed to the annual value of $1.1 million for FY2020, which is 2574.17% up from last year.
  • As of Q2 2025, BioNTech SE's Other Accumulated Expenses stood at -$8.3 million, which was down 369.35% from -$6.7 million recorded in Q1 2025.
  • Over the past 5 years, BioNTech SE's Other Accumulated Expenses peaked at $1.1 million during Q1 2021, and registered a low of -$16.9 million during Q3 2022.
  • For the 5-year period, BioNTech SE's Other Accumulated Expenses averaged around -$6.7 million, with its median value being -$5.8 million (2023).
  • As far as peak fluctuations go, BioNTech SE's Other Accumulated Expenses skyrocketed by 7108.06% in 2023, and later crashed by 23179.81% in 2024.
  • Over the past 5 years, BioNTech SE's Other Accumulated Expenses (Quarter) stood at $1.1 million in 2021, then plummeted by 1660.32% to -$16.9 million in 2022, then skyrocketed by 71.08% to -$4.9 million in 2023, then plummeted by 231.8% to -$16.3 million in 2024, then skyrocketed by 49.16% to -$8.3 million in 2025.
  • Its Other Accumulated Expenses was -$8.3 million in Q2 2025, compared to -$6.7 million in Q1 2025 and -$16.3 million in Q3 2024.